• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用MRI预测胶质母细胞瘤假性进展与进展的机器学习模型:一项多机构研究(KROG 18-07)。

Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07).

作者信息

Jang Bum-Sup, Park Andrew J, Jeon Seung Hyuck, Kim Il Han, Lim Do Hoon, Park Shin-Hyung, Lee Ju Hye, Chang Ji Hyun, Cho Kwan Ho, Kim Jin Hee, Sunwoo Leonard, Choi Seung Hong, Kim In Ah

机构信息

Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 13620, Korea.

Artificial Intelligence Research and Development Laboratory, SELVAS AI Incorporation, Seoul 08594, Korea.

出版信息

Cancers (Basel). 2020 Sep 21;12(9):2706. doi: 10.3390/cancers12092706.

DOI:10.3390/cancers12092706
PMID:32967367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7564954/
Abstract

Some patients with glioblastoma show a worsening presentation in imaging after concurrent chemoradiation, even when they receive gross total resection. Previously, we showed the feasibility of a machine learning model to predict pseudoprogression (PsPD) versus progressive disease (PD) in glioblastoma patients. The previous model was based on the dataset from two institutions (termed as the Seoul National University Hospital (SNUH) dataset, = 78). To test this model in a larger dataset, we collected cases from multiple institutions that raised the problem of PsPD vs. PD diagnosis in clinics (Korean Radiation Oncology Group (KROG) dataset, = 104). The dataset was composed of brain MR images and clinical information. We tested the previous model in the KROG dataset; however, that model showed limited performance. After hyperparameter optimization, we developed a deep learning model based on the whole dataset ( = 182). The 10-fold cross validation revealed that the micro-average area under the precision-recall curve (AUPRC) was 0.86. The calibration model was constructed to estimate the interpretable probability directly from the model output. After calibration, the final model offers clinical probability in a web-user interface.

摘要

一些胶质母细胞瘤患者在同步放化疗后影像学表现恶化,即使他们接受了全切除。此前,我们展示了一种机器学习模型在预测胶质母细胞瘤患者假性进展(PsPD)与疾病进展(PD)方面的可行性。先前的模型基于两个机构的数据集(称为首尔国立大学医院(SNUH)数据集,n = 78)。为了在更大的数据集中测试该模型,我们收集了多个机构中在临床上面临PsPD与PD诊断问题的病例(韩国放射肿瘤学组(KROG)数据集,n = 104)。该数据集由脑部MR图像和临床信息组成。我们在KROG数据集中测试了先前的模型;然而,该模型表现有限。经过超参数优化后,我们基于整个数据集(n = 182)开发了一个深度学习模型。10折交叉验证显示,精确召回率曲线下的微平均面积(AUPRC)为0.86。构建校准模型以直接从模型输出估计可解释的概率。校准后,最终模型在网络用户界面中提供临床概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/68b09bc3612c/cancers-12-02706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/800d8c411ae0/cancers-12-02706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/eb04177ff5f8/cancers-12-02706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/8c39e494e195/cancers-12-02706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/68b09bc3612c/cancers-12-02706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/800d8c411ae0/cancers-12-02706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/eb04177ff5f8/cancers-12-02706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/8c39e494e195/cancers-12-02706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae0e/7564954/68b09bc3612c/cancers-12-02706-g004.jpg

相似文献

1
Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07).使用MRI预测胶质母细胞瘤假性进展与进展的机器学习模型:一项多机构研究(KROG 18-07)。
Cancers (Basel). 2020 Sep 21;12(9):2706. doi: 10.3390/cancers12092706.
2
Establishment of noninvasive diabetes risk prediction model based on tongue features and machine learning techniques.基于舌象特征和机器学习技术的无创糖尿病风险预测模型的建立。
Int J Med Inform. 2021 May;149:104429. doi: 10.1016/j.ijmedinf.2021.104429. Epub 2021 Feb 22.
3
Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma.基于机器学习算法预测胶质母细胞瘤中的假性进展与进展。
Sci Rep. 2018 Aug 21;8(1):12516. doi: 10.1038/s41598-018-31007-2.
4
Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.在接受放疗和替莫唑胺联合治疗的胶质母细胞瘤中,从假性进展中区分真性进展:标准和高 b 值扩散加权成像的对比研究。
Radiology. 2013 Dec;269(3):831-40. doi: 10.1148/radiol.13122024. Epub 2013 Oct 28.
5
Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.通过视觉检查磁共振相对脑血容量图来区分多形性胶质母细胞瘤患者病情进展与假性进展的价值有限。
CNS Oncol. 2017 Oct;6(4):297-306. doi: 10.2217/cns-2017-0013. Epub 2017 Oct 6.
6
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.O-6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化状态可预测新诊断的胶质母细胞瘤患者同步放化疗后假性进展的发生率及预后。
J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163.
7
Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.通过MGMT启动子甲基化分层的胶质母细胞瘤亚组中,成像参数对预测假性进展的不同诊断价值。
Eur Radiol. 2017 Jan;27(1):255-266. doi: 10.1007/s00330-016-4346-y. Epub 2016 Apr 5.
8
Pseudoprogression in glioblastoma patients: the impact of extent of resection.胶质母细胞瘤患者的假性进展:手术切除范围的影响。
J Neurooncol. 2016 Feb;126(3):559-66. doi: 10.1007/s11060-015-2001-0. Epub 2015 Nov 25.
9
Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.胶质母细胞瘤行同期放化疗治疗:定量动态对比增强磁共振成像鉴别真性进展与假性进展。
Radiology. 2015 Mar;274(3):830-40. doi: 10.1148/radiol.14132632. Epub 2014 Oct 21.
10
IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.异柠檬酸脱氢酶(IDH)突变和O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化与接受同步和辅助替莫唑胺化疗放疗的多形性胶质母细胞瘤患者的假性进展及预后改善相关。
Clin Neurol Neurosurg. 2016 Dec;151:31-36. doi: 10.1016/j.clineuro.2016.10.004. Epub 2016 Oct 12.

引用本文的文献

1
Artificial intelligence algorithms for differentiating pseudoprogression from true progression in high-grade gliomas: A systematic review and meta-analysis.用于区分高级别胶质瘤假性进展与真性进展的人工智能算法:一项系统综述和荟萃分析
Neurosurg Rev. 2025 Aug 6;48(1):591. doi: 10.1007/s10143-025-03718-4.
2
Radiomics for differentiating radiation-induced brain injury from recurrence in gliomas: systematic review, meta-analysis, and methodological quality evaluation using METRICS and RQS.用于鉴别胶质瘤放疗后脑损伤与复发的影像组学:使用METRICS和RQS的系统评价、Meta分析及方法学质量评估
Eur Radiol. 2025 Feb 12. doi: 10.1007/s00330-025-11401-x.
3

本文引用的文献

1
Machine learning and glioma imaging biomarkers.机器学习与脑胶质瘤影像标志物
Clin Radiol. 2020 Jan;75(1):20-32. doi: 10.1016/j.crad.2019.07.001. Epub 2019 Jul 29.
2
Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging.优化神经肿瘤影像学:胶质瘤成像深度学习方法综述
Cancers (Basel). 2019 Jun 14;11(6):829. doi: 10.3390/cancers11060829.
3
DRRNet: Dense Residual Refine Networks for Automatic Brain Tumor Segmentation.DRRNet:用于自动脑肿瘤分割的密集残差细化网络。
Predicting IDH and ATRX mutations in gliomas from radiomic features with machine learning: a systematic review and meta-analysis.
利用机器学习从影像组学特征预测胶质瘤中的异柠檬酸脱氢酶(IDH)和α-地中海贫血/智力低下综合征X连锁基因(ATRX)突变:一项系统综述和荟萃分析
Front Radiol. 2024 Oct 31;4:1493824. doi: 10.3389/fradi.2024.1493824. eCollection 2024.
4
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O-methylguanine-methyltransferase promoter methylation status.基于多参数磁共振成像和O-甲基鸟嘌呤-甲基转移酶启动子甲基化状态,利用机器学习区分胶质母细胞瘤中的假性进展与真性进展
Neurooncol Adv. 2024 Oct 3;6(1):vdae159. doi: 10.1093/noajnl/vdae159. eCollection 2024 Jan-Dec.
5
Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.神经肿瘤学中的人工智能反应评估(AI-RANO),第 2 部分:标准化、验证和良好临床实践的建议。
Lancet Oncol. 2024 Nov;25(11):e589-e601. doi: 10.1016/S1470-2045(24)00315-2.
6
Radiogenomics: bridging the gap between imaging and genomics for precision oncology.放射基因组学:弥合影像学与基因组学之间的差距,实现精准肿瘤学。
MedComm (2020). 2024 Sep 9;5(9):e722. doi: 10.1002/mco2.722. eCollection 2024 Sep.
7
Added value of dynamic contrast-enhanced MR imaging in deep learning-based prediction of local recurrence in grade 4 adult-type diffuse gliomas patients.动态对比增强磁共振成像在基于深度学习预测4级成人型弥漫性胶质瘤患者局部复发中的附加价值
Sci Rep. 2024 Jan 25;14(1):2171. doi: 10.1038/s41598-024-52841-7.
8
Personalized Treatment of Glioblastoma: Current State and Future Perspective.胶质母细胞瘤的个性化治疗:现状与未来展望
Biomedicines. 2023 May 30;11(6):1579. doi: 10.3390/biomedicines11061579.
9
Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma.正电子发射断层扫描(PET)与灌注加权磁共振成像(MRI)技术在区分胶质瘤治疗相关异常与肿瘤进展方面的头对头比较
Cancers (Basel). 2023 May 5;15(9):2631. doi: 10.3390/cancers15092631.
10
Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients.用于预测胶质母细胞瘤患者经组织病理学证实的假性进展的放射组学分析
Adv Radiat Oncol. 2022 Feb 6;8(1):100916. doi: 10.1016/j.adro.2022.100916. eCollection 2023 Jan-Feb.
J Med Syst. 2019 Jun 8;43(7):221. doi: 10.1007/s10916-019-1358-6.
4
GUESS: projecting machine learning scores to well-calibrated probability estimates for clinical decision-making.用于临床决策的机器学习评分向良好校准概率估计的投射。
Bioinformatics. 2019 Jul 15;35(14):2458-2465. doi: 10.1093/bioinformatics/bty984.
5
Prediction of Pseudoprogression versus Progression using Machine Learning Algorithm in Glioblastoma.基于机器学习算法预测胶质母细胞瘤中的假性进展与进展。
Sci Rep. 2018 Aug 21;8(1):12516. doi: 10.1038/s41598-018-31007-2.
6
Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM.区分假性进展与真性进展:GBM 中的影像学、生物学和临床线索分析。
J Neurooncol. 2018 Aug;139(1):145-152. doi: 10.1007/s11060-018-2855-z. Epub 2018 May 16.
7
Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas.深度学习卷积神经网络准确分类脑胶质瘤中的基因突变。
AJNR Am J Neuroradiol. 2018 Jul;39(7):1201-1207. doi: 10.3174/ajnr.A5667. Epub 2018 May 10.
8
Binary Classifier Calibration Using an Ensemble of Piecewise Linear Regression Models.使用分段线性回归模型集成进行二元分类器校准
Knowl Inf Syst. 2018 Jan;54(1):151-170. doi: 10.1007/s10115-017-1133-2. Epub 2017 Nov 17.
9
Recent Developments of 18F-FET PET in Neuro-oncology.神经肿瘤学中 18F-FET PET 的最新进展。
Curr Med Chem. 2018;25(26):3061-3073. doi: 10.2174/0929867325666171123202644.
10
Residual Convolutional Neural Network for the Determination of Status in Low- and High-Grade Gliomas from MR Imaging.基于残差卷积神经网络的磁共振成像对低级别和高级别脑胶质瘤状态的预测。
Clin Cancer Res. 2018 Mar 1;24(5):1073-1081. doi: 10.1158/1078-0432.CCR-17-2236. Epub 2017 Nov 22.